Search | TVST | ARVO Journals

Showing 1 – 14 of 14

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Multimodal Photoacoustic Microscopy, OCT, and Fluorescence Imaging for Tracking of Human Induced Pluripotent Stem Cell Derived RPE In Vivo

Phuc Nguyen; Athanasios J Karoukis; Wei Qian; Lisheng Chen; N Dayanthi Perera; Dongshan Yang; Qitao Zhang; Josh Zhe; Jessica Henry; Bing Liu; Wei Zhang; Abigail T Fahim; Xueding Wang; Yannis M. Paulus

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3828.

ARVO Annual Meeting Abstract June 2023

Under-prenylated rab GTPases in choroideremia RPE cells

Abigail T Fahim; Lisheng Chen; Athanasios J Karoukis; N Dayanthi Perera; Kecia L Feathers; Robin R Ali; Debra A Thompson

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3006.

ARVO Annual Meeting Abstract June 2022

Delivery of a hydrophobic small molecule LXR agonist via sHDL nanoparticles in a preclinical model of dry AMD

Eric Weh; Ling Mei; Lisa Walsh; Minzhi Yi; Cheng-mao Lin; Abigail T Fahim; Anna Schwendeman; Cagri Besirli

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):290 – F0093.

ARVO Annual Meeting Abstract June 2022

Visual acuity and full-field stimulus thresholds (FST) over 2 years in the RUSH2A study: annual rates of change from mixed effects modeling

Peiyao Cheng; David G Birch; Jacque L Duncan; Frederick L Ferris; Maureen G Maguire; Allison R. Ayala; Janet K Cheetham; Todd Durham; Abigail T Fahim; Rachel M Huckfeldt; Michel Michaelides; Mark E Pennesi; Jose Alain Sahel; Katarina Stingl; Ajoy Vincent; Christina Y Weng

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4480 – F0267.

Genetics June 2021

Characterization of the Spectrum of Ophthalmic Changes in Patients With Alagille Syndrome

PDF

Mariana Matioli da Palma; Austin D. Igelman; Cristy Ku; Amanda Burr; Jia Yue You; Emily M. Place; Nan-Kai Wang; Jin Kyun Oh; Kari E. Branham; Xinxin Zhang; Jeeyun Ahn; Michael B. Gorin; Byron L. Lam; Cecinio C. Ronquillo; Paul S. Bernstein; Aaron Nagiel; Rachel Huckfeldt; Michelle T. Cabrera; John P. Kelly; Benjamin Bakall; Alessandro Iannaccone; Robert B. Hufnagel; Wadih M. Zein; Robert K. Koenekoop; David G. Birch; Paul Yang; Abigail T. Fahim; Mark E. Pennesi
TAGS: arteriohepatic dysplasia, eye
Invest. Ophthalmol. Vis. Sci.. 2021; 62(7):27. https://doi.org/10.1167/iovs.62.7.27

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

The prevalence, visual significance, and genotype-phenotype associations of foveal hypoplasia in inherited retinal diseases

Rebhi Abuzaitoun; Kari Branham; Dana Schlegel; Thiran Jayasundera; Abigail T Fahim

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3232.

ARVO Annual Meeting Abstract June 2021

Factors Affecting Rates of Genetic Testing for Inherited Retinal Degenerations

Peter Yu Cheng Zhao; Kari E Branham; Dana Schlegel; Abigail T Fahim; Thiran Jayasundera

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):162.

Articles October 2020

The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline

PDF

David G. Birch; Peiyao Cheng; Jacque L. Duncan; Allison R. Ayala; Maureen G. Maguire; Isabelle Audo; Janet K. Cheetham; Todd A. Durham; Abigail T. Fahim; Frederick L. Ferris, III; Elise Heon; Rachel M. Huckfeldt; Alessandro Iannaccone; Naheed W. Khan; Eleonora M. Lad; Michel Michaelides; Mark E. Pennesi; Katarina Stingl; Ajoy Vincent; Christina Y. Weng; for the Foundation Fighting Blindness Consortium Investigator Group
TAGS: electroretinography, visual acuity
Trans. Vis. Sci. Tech.. 2020; 9(11):9. https://doi.org/10.1167/tvst.9.11.9

Includes: Supplemental Content

Review June 2020

Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium

PDF

Debra A. Thompson; Alessandro Iannaccone; Robin R. Ali; Vadim Y. Arshavsky; Isabelle Audo; James W. B. Bainbridge; Cagri G. Besirli; David G. Birch; Kari E. Branham; Artur V. Cideciyan; Steven P. Daiger; Deniz Dalkara; Jacque L. Duncan; Abigail T. Fahim; John G. Flannery; Roberto Gattegna; John R. Heckenlively; Elise Heon; K. Thiran Jayasundera; Naheed W. Khan; Henry Klassen; Bart P. Leroy; Robert S. Molday; David C. Musch; Mark E. Pennesi; Simon M. Petersen-Jones; Eric A. Pierce; Rajesh C. Rao; Thomas A. Reh; Jose A. Sahel; Dror Sharon; Paul A. Sieving; Enrica Strettoi; Paul Yang; David N. Zacks; The Monaciano Consortium
TAGS: outcome measures, retinal diseases, surrogate endpoints, genetics, vision, natural history, ethics, gene therapy
Trans. Vis. Sci. Tech.. 2020; 9(7):2. https://doi.org/10.1167/tvst.9.7.2

ARVO Annual Meeting Abstract July 2019

X-Chromosome Inactivation is a Biomarker of Clinical Severity in Female Carriers of X-linked Retinitis Pigmentosa

Abigail T Fahim; Lori S Sullivan; Sara J Bowne; Kaylie Webb-Jones; Dianna K.H. Wheaton; Kari E Branham; Mohammad Othman; Athanasios J Karoukis; Chris Andrews; John R Heckenlively; David G Birch; Stephen P Daiger

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2961.

ARVO Annual Meeting Abstract July 2018

The journey from clinical to genetic diagnosis in Stargardt disease

Dana Schlegel; Kari E Branham; John R Heckenlively; Abigail T Fahim; Thiran Jayaundera

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1433.

ARVO Annual Meeting Abstract March 2012

Factors Modifying Severity and Penetrance in Males and Females with Retinitis Pigmentosa Caused by Mutations in the X-Linked RPGR Gene

Stephen P. Daiger; Michelle R. O'Byrne; Abigail T. Fahim; Sara J. Bowne; Lori S. Sullivan; David G. Birch; Kaylie D. Webb; Dianna K. Wheaton

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4540.

ARVO Annual Meeting Abstract March 2012

Progressive Foveal Outer Retinal Degeneration and a Therapeutic Window for Gene Therapy in Achromatopsia

Abigail T. Fahim; Sarwar Zahid; Kari Branham; Naheed Khan; Susanne Kohl; Bernd Wissinger; K T. Jayasundera; John R. Heckenlively

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4553.

ARVO Annual Meeting Abstract April 2011

Assessment of Phenotypic Variability Among Female Carriers of X-linked Retinitis Pigmentosa (xlRP) due to RPGR Mutations

Kaylie D. Webb; Hemaxi M. Patel; Sara J. Bowne; Lori S. Sullivan; Abigail T. Fahim; Stephen P. Daiger; Dennis R. Hoffman; David G. Birch; Dianna K. Wheaton

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4981.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Multimodal Photoacoustic Microscopy, OCT, and Fluorescence Imaging for Tracking of Human Induced Pluripotent Stem Cell Derived RPE In Vivo

Under-prenylated rab GTPases in choroideremia RPE cells

Delivery of a hydrophobic small molecule LXR agonist via sHDL nanoparticles in a preclinical model of dry AMD

Visual acuity and full-field stimulus thresholds (FST) over 2 years in the RUSH2A study: annual rates of change from mixed effects modeling

Characterization of the Spectrum of Ophthalmic Changes in Patients With Alagille Syndrome

The prevalence, visual significance, and genotype-phenotype associations of foveal hypoplasia in inherited retinal diseases

Factors Affecting Rates of Genetic Testing for Inherited Retinal Degenerations

The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline

Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium

X-Chromosome Inactivation is a Biomarker of Clinical Severity in Female Carriers of X-linked Retinitis Pigmentosa

The journey from clinical to genetic diagnosis in Stargardt disease

Factors Modifying Severity and Penetrance in Males and Females with Retinitis Pigmentosa Caused by Mutations in the X-Linked RPGR Gene

Progressive Foveal Outer Retinal Degeneration and a Therapeutic Window for Gene Therapy in Achromatopsia

Assessment of Phenotypic Variability Among Female Carriers of X-linked Retinitis Pigmentosa (xlRP) due to RPGR Mutations

To View More...

You must be signed into an individual account to use this feature.